Cardiovascular activity of naturally occurring lignans

Phytomedicine

Volumn 4, Issue 2, 1997, Pages 151-166

  Ghisalberti, E L ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

Author keywords

Antihypertensive activity; Antioxidant effect; Ca2+ antagonism; cAMP phosphodiesterase inhibition; Endothelin antagonism; Lignans; Mammalian lignans; Neolignans; PAF antagonism

Indexed keywords

ANIMALIA; MAMMALIA;

EID: 0001365806     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0944-7113(97)80063-3     Document Type: Article

References (121)

1. Abe, M., Morikawa, M., Inoue, M., Tsuboi, M.: Inhibitory effect of 3,3-dibenzylbuta-1,4-diol a mammalian lignan on the calcium channel in rabbit femoral artery. Res. Commun. Chem. Pathol. Pharmacol. 69: 2271-2284, 1990.
2. Adlercreutz, H., Vanderwildt, J., Kinzel, J., Attalla, H., Wahala, K., Makela, T., Hase, T., Fotsis, T.: Lignan and isoflavonoid conjugates in human urine. J. Ster. Biochem. Mol. Biol. 52: 97-103, 1995.
3. Adlercreutz, H.: Phytoestrogens: epidemology and a possible role in cancer prevention. Environ. Health Perspect. 103: 103-112, 1995.
4. Ahmad, M., Aftab, K.: Hypotensive action of syringin from Syringa vitlgaris. Phytotherapy Res. 9: 452-454, 1995.
5. Ayres, D. C., Loike, J. D.: Lignans. Chemical, biological and clinical properties. Cambridge University Press, Cambridge, pp. 1-402, 1990.
6. Bannwart, C., Adlercreutz, H., Wahala, K., Brunow, G., Hase, T.: Detection and identification of the plant lignans lariciresinol, isolariciresinol and secoisolariciresinol in human urine. Clin. Chim. Acta 180: 293-302, 1989.
7. Bao, G., Yu, D., Qu, J., Zheng, Y. F., Xu, L.: Oxygen free radical inhibition of potassium channel activity in cardiac myocytes and antagonistic effect of salvianolic acid A. Zhongguo Yixue Kexueyuan Xuebao 15: 320-324, 1993; Chem. Abstr. 120: 315 499, 1994.
8. Bao, G., Yu, D., Qu, J., Zheng, Y. F., Xu, L.: Oxygen free radical inhibition of potassium channel activity in cardiac myocytes and antagonistic effect of salvianolic acid A. Zhongguo Yixue Kexueyuan Xuebao 15: 320-324, 1993; Chem. Abstr. 120: 315 499, 1994.
9. Barrett, J.: Phytoestrogens: friends or foes? Environ. Health Perspect. 104: 478-482, 1996.
10. Biftu, T., Stevenson, R.: Natural 2, 5-bisaryl-tetrahydrofuran lignans: platelet-activating factor antagonists. Phytother. Res. 1: 97-106, 1987.
11. Braquet, P., Godfroid, J. J.: PAF-acether specific binding sites. Part 2. Design of specific antagonists. Trends in Pharm. Sci. 397-399, 1986.
12. Braquet, P., Senn, N., Fagoo, M., Garay, R., Robin, J. P.; Esanu, A., Chabrier, E., Godfrain, T.: Mammalian lignans: a possible involvment in endogenous digitalis activity. C. R. Acad. Sci. Ser. 3 302: 443-448, 1986.
13. Braquet, P., Senn, N., Esanu, A., Garay, R.: Inhibition of the erythrocyte sodium-potassium-pump by mammalian lignans. Dev. Nephrol. 18: 165-167, 1987.
14. Castro, M. A., Gordaliza, M., Miguel del Corral, J. M., San Feliciano, A.: The distribution of lignanoids in the Order Coniferae. Phytochemistry 41: 995-1011, 1996.
15. Castro-Faria-Neto, H. C., Bozxza, P. T., Cruz, H. N., Vilva, C. L. M., Violante, F. A., Barbosa, J. M., Thomas, G., Martins, M. A., Tibirica, E. V., Noel, E, Cordeiro, R. S. B.: Yangambin - a new natural-occurring platelet-activating factor receptor antagonist-binding and in vitro functional studies. Plant Med. 61: 101-105, 1995 a.
16. Castro-Faria-Neto, H. C., Araujo, C. V., Moreira, S., Bozxza, P. T., Cruz, Thomas, G., Barbosa, J. M., Cordeiro, R. S. B., Tibirica, E. V.: Yangambin - a new natural-occurring platelet-activating factor receptor antagonist - in vivo pharmacological studies. Planta Med. 61: 106-112, 1996 b.
17. Chan, W.-S., Wen, P.-C., Chiang, H.-C.: Structure-activity relationship of caffeic acid analogs on xanthine oxidase inhibition. Anticancer Res. 15: 703-707, 1995.
18. Chang, M. N., Han, G-Q., Arison, B. H., Springer, J. P., Hwang, S.-B., Shen, T. Y.: Neolignans from Piper futokadsura. Phytochemistry 24: 2079-2082, 1985.
19. Chen, C. C., Huang, Y. L., Chen, H. T., Chen, Y. P., Hsu, H. Y., Sheu, J.: The platelet aggregation inhibiting activity of honokiol, magnolol and related compounds. Chung-bua Yao Hsueb Tsa Chih 40: 15-19, 1988; Chem. Abstr. 110: 107 597, 1989.
20. Chen, C. C., Huang, Y. L., Chen, H. T., Chen, Y. P., Hsu, H. Y., Sheu, J.: The platelet aggregation inhibiting activity of honokiol, magnolol and related compounds. Chung-bua Yao Hsueb Tsa Chih 40: 15-19, 1988; Chem. Abstr. 110: 107 597, 1989.
21. Chen, Z., Yu, P., Xu, P.: Anti-PAF constituents, 2, 5-diaryltetrahydrofuran type lignans, from Piper futokadsura Sied, et Zucc. Zhongguo Zhongyao Zazhi 18: 292-294, 1993; Chem. Abstr. 119: 173 853, 1993.
22. Chen, Z., Yu, P., Xu, P.: Anti-PAF constituents, 2, 5-diaryltetrahydrofuran type lignans, from Piper futokadsura Sied, et Zucc. Zhongguo Zhongyao Zazhi 18: 292-294, 1993; Chem. Abstr. 119: 173 853, 1993.
23. Chiang, W.-T., Wang, Y.-P.: Study of the effects of β-(3, 4-dihydroxyphenyl)lactic acid, a water soluble component in Salvia miltorrhiza, and persantin on ischemic myocardium and coronary artery. Yao Hsueb T'ung Pao 16: 59, 1981; Chem. Abstr. 95: 143 964, 1981.
24. Chiang, W.-T., Wang, Y.-P.: Study of the effects of β-(3, 4-dihydroxyphenyl)lactic acid, a water soluble component in Salvia miltorrhiza, and persantin on ischemic myocardium and coronary artery. Yao Hsueb T'ung Pao 16: 59, 1981; Chem. Abstr. 95: 143 964, 1981.
25. Cooley, G., Farrant, R. D., Kirk, D. N., Patel, S., Wynn, S., Buckingham, M. J., Hawkes, G. E., Hursthouse, M. B., Galas, A. M. R., Lawson, A. M., Setchell, K. D. R.: Structural analysis of the urinary lignan trans-2, 3-bis(3-hydroxylbenzyl)-butan-4-olide ('Enterolactone'). A 400 MHz nuclear magnetic resonance study for the solution state and X-ray study for the crystal state. J. Chem. Soc. Perkin Trans. II: 489-497, 1984.
26. Cooper, K., Fray, M. J., Parry, M. J., Richardson, K., Steele, J.: Enantiodifferentiation of dihydropyridine PAF antagonists. Bioorg. Med. Chem. lett. 5: 3085-3090, 1995.
27. Cordell, G. A.: Changing strategies in natural products chemistry. Phytochemistry 40: 1585-1612, 1995.
28. Deyama, T., Nishibe, S., Kitagawa, S., Ogihara, Y., Takeda, T., Omoto, T., Nikaido, T., Sankawa, U.: Inhibitors of cAMP phosphodiesterase in medicinal plants. XIV. Inhibition of adenosine 3', 5'-cyclic monophosphate phosphodiesterase by lignan glucosides of Eucommia bark. Chem. Pharm. Bull. 36: 435-439, 1988.
29. Dinkova- Kostova, A. T., Gang, D. R., Davin, L. B., Bedgar, D. L., Chu, A., Lewis, N. G.: (+)-Pinoresinol/(+)-lariciresinol reductase from Forsythia intermedia. J. Biol. Chem. 271: 29 473-29 482, 1996.
30. Dorigo, P., Fraccarollo, D., Santostasi, G., Maragno, I., Floreani, M., Borea, P. A., Mosti, L., Sansebastiano, L., Fossa, P., Orsini, E, Benetollo, F., Bombieri, G.: Synthesis and cardiotonic activity of novel pyrimidine derivatives: crystallographic and X-ray studies. J. Med. Chem. 39: 3671-3683, 1996.
31. Fung, K. P., Zeng, L. H., Wu, J., Wong, H. N. C., Lee, C. M., Chang, H. M., Wu, T. S.: Demonstration of the myocardial salvage effect of lithospermic acid B isolated from the aqueous extract of Salvia miltorrbiza. Life Sci. 52: PL 239-PL 244, 1993.
32. + channels. Trends Pharmacol. Sci. 16: 1-4, 1995.
33. Gordon, M. H.: Dietary oxidants in disease prevention. Nat. Prod. Rep. 13: 265-273, 1996.
34. Gottlieb, O. R.: Lignans. In: Herz, W., Grisebach, H., Kirby, G. W. (Eds.): Progress in the chemistry of natural products, vol. 35. Springer-Verlag, Vienna, pp. 1-72, 1978.
35. Gottlieb, O. R., Yoshida, M.: Neolignans. In: Rowe, J. W. (Ed.): Natural Products of Woody Plants, vol. 1. Springer-Verlag, Berlin, pp. 439-511, 1989.
36. Hansen, K., Adsersen, A., Christensen, S. B., Jensen, S. R., Nyman, U., Smitt, U. W.: Isolation of an angiotensin converting enzyme (ACE) inhibitor from Olea europea and Olea lancea. Phytomedicine 2: 319-325, 1996.
37. Han, G.: PAF receptor antagonistic principles from Chinese traditional drugs. Prog. Nat. Sci. 5: 299-306, 1995.
38. Han, G.-Q., Chang, M. N., Hwang, S.-B.: The investigation of lignans of Sargentodoxa cuneata (Oliv) Rehd and Wils. Yaoxue Xuebao 21: 68-70, 1986; Chem. Abstr. 104: 203 866, 1986.
39. Han, G.-Q., Chang, M. N., Hwang, S.-B.: The investigation of lignans of Sargentodoxa cuneata (Oliv) Rehd and Wils. Yaoxue Xuebao 21: 68-70, 1986; Chem. Abstr. 104: 203 866, 1986.
40. Han, G., My, Y., Li, C.: The studies of natural PAF antagonistic neolignans from Piper genus and their structure-activity rela-tionships. Beijing Yike Daxue Xuebao 24: 347-360, 1992; Chem. Abstr. 119: 91 139, 1993.
41. Han, G., My, Y., Li, C.: The studies of natural PAF antagonistic neolignans from Piper genus and their structure-activity rela-tionships. Beijing Yike Daxue Xuebao 24: 347-360, 1992; Chem. Abstr. 119: 91 139, 1993.
42. Herman, C., Adlercreutz, T., Goldin, B. R., Gorbach, S. L., Hockerstedt, K. A. V., Markkanen, M. H., Watanabe, S., Hamalainen, E. K., Makela, T. H., Wahala, K. T., Hase, T. A., Fotsis, T.: Soybean phytoestrogen intake and cancer risk. J. Nutr. 125: 757 S-770 S, 1995.
43. Hikino, H., Ogata, K., Konno, C., Sato, S.: Studies on the constituents of Ephedra. 12. Validity of the oriental medicines. Part 41. Hypotensive actions of ephedradines, macrocyclic spermine alkaloids of Ephedra roots. Planta Med. 48: 290-293, 1983.
44. Hirano, T., Oka, K., Naito, T., Hosaka, K., Mitsuhashi, H.: Endogenous digoxinlikle activity of mammalian lignans and their derivatives. Res. .Commun. Chem. Pathol. Pharmacol. 64: 227-240, 1989.
45. Hong, C. Y., Huang, S. S., Tsai, S. K.: Magnolol reduces infarct size and suppresses ventricular arrhythmia in rats subjected to coronary ligation. Clin. Exp. Pharmacol. Physiol. 23: 660-664, 1996.
46. Hosford, D., Braquet, P.: Antagonists of platelet-activating factor: chemistry, pharmacology and clinical applications. Prog. Med. Chem. 27: 325-380, 1990.
47. Hussain, R. A., Dickey, J. K., Rosser, M. P., Matson, J. A., Kozlowski, M. R., Brittain, R. J., Webb, M. L., Rose, P. M., Fernandes, P.: A novel class of non-peptide antagonists isolated from the medicinal herb Phyllanthus niruri. J. Nat. Prod. 58: 1515-1520, 1995.
48. Hwang, S.-B., Lam. M.-H., Biftu, T., Beattie, T. R., Shen, T.-Y.: Trans-2, 5-Bis-(3, 4, 5-trimethoxyphenyl)tetrahydrofuran. An orally active specific and competitive receptor antagonist of platelet activating factor. J. Biol. Chem. 260: 15 639-15 645, 1985.
49. Ichikawa, K., Kinoshita, T., Nishibe, S., Sankawa, U.: The calcium antagonistic activity of lignans. Chem. Pharm. Bull. 34: 3514-3517, 1986.
50. Iwasaki, T., Kondo, K., Nishtani, T., Kuroda, T., Hirakoso, K., Ohtani, A., Takashima, K.: Arylnaphthalene lignans as novel series of hypolipidemic agent raising high-density lipoprotein level. Chem. Pharm. Bull. 43: 1701-1705, 1995.
51. Jensen, S., Hansen, J., Boll, P. M.: Lignans and neolignans from Piperaceae. Phytochemistry 33: 523-530, 1993.
52. Jin, J., Yu, Z., Zhong, M.: Antiarrhythmic principle of Justicia procumenens L. Yaoxne Tongbao 17, 365, 1982; Chem. Abstr. 97: 78 760, 1982.
53. Jin, J., Yu, Z., Zhong, M.: Antiarrhythmic principle of Justicia procumenens L. Yaoxne Tongbao 17, 365, 1982; Chem. Abstr. 97: 78 760, 1982.
54. Kamata, K., Itzuka, T., Nagai, M., Kasuya, Y.: Endothelium-dependent vasodilator effects of the extracts from Salviae miltiorrhizae radix. A study on the identification of lithospermic acid B in the extracts. Gen. Pharmacol. 24: 977-981, 1993.
55. Kamata, K., Noguchi, M., Nagai, M.: Hypotensive effects of lithospermic acid B isolated from the extract of salviae miltiorrhizae radix in the rat. Gen. Pharmacol. 25. 69-73, 1994.
56. Katsuzaki, H., Osawa, T., Kawakishi, S.: Chemistry and antioxidative activity of lignan glucosides in sesame seed. In: Ho, C.-T., Osawa, T., Huang, M.-T., Rosen, R. T. (Eds.): Food phytochemicals for cancer prevention II. American Chemical Society, Washington DC, pp. 275-280, 1994.
57. Kita, S., Matsumura, Y., Morimoto, S., Akimoto, K., Furuya, M., Oka, N., Tanaka, T.: Antihypertensive effect of sesamin. 2. Protection against two-kidney, one-clip renal hypertension and cardiovascular hypertrophy. Bio. Pharm. Bull. 18: 1283-1285, 1995.
58. Kitagawa, S., Hisada, S., Nishibe, S.: Phenolic compounds from Forsythia leaves. Phytochemistry 23: 1635-1636, 1984.
59. Kumada, Y., Naganawa, H., Takeuchi, T., Umezawa, H., Yamashita, K., Watanabe, K.: Biochemical activities of the derivatives of dehydrocaffeic acid lactone. J. Antibiotics 31: 106-111, 1978.
60. 2+ channel antagonistic compound from the methanol extract. Chem. Pharm. Bull. 39: 1551-1555, 1991.
61. Lewis, N. G., Davin, L. B.: Evolution of lignan and neolignan biochemical pathways. In: Nes, W. D. (Ed.): Isopentenoids and Other Natural Products. Evolution and Function. ACS Symposium Series 562, American Chemical Society, Washington, D. C., pp. 202-246, 1994.
62. Li, D.-Y., Xu, L.-N., Liu, X.-Q.: Effects of watersoluble components isolated from Salvia miltiorrhiza on oxygen free radical generation and lipid peroxidation. J. Chin. Pharm. Sci. 4: 107-112, 195; Chem. Abstr. 123: 246 362, 1995.
63. Li, D.-Y., Xu, L.-N., Liu, X.-Q.: Effects of watersoluble components isolated from Salvia miltiorrhiza on oxygen free radical generation and lipid peroxidation. J. Chin. Pharm. Sci. 4: 107-112, 195; Chem. Abstr. 123: 246 362, 1995.
64. Lo, Y. C., Teng, C. M., Chen, C. F., Chen, C. C., Hong, C. Y: Magnolol and hinokiol isolated from Magnolia officinalia protect rat heart. Biochem. Pharmacol. 47: 549-553, 1994.
65. Ma, Y., Han, G. Q., Li, C. L., Cheng, J. R., Arison, B. H., Hwang, S. B.: Neolignans from Piper polysyphorum C. DC. Yaoxue Xuebao 26: 345-350, 1991; Chem. Abstr. 115: 247 446, 1991.
66. Ma, Y., Han, G. Q., Li, C. L., Cheng, J. R., Arison, B. H., Hwang, S. B.: Neolignans from Piper polysyphorum C. DC. Yaoxue Xuebao 26: 345-350, 1991; Chem. Abstr. 115: 247 446, 1991.
67. Ma, Y., Han, G. Q., Wang, Y. Y.: PAF antagonistic benzofuran neolignans from Piper kadsura. Yaoxue Xuebao 28: 370-373, 1993; Chem. Abstr. 119: 151 841, 1993.
68. Ma, Y., Han, G. Q., Wang, Y. Y.: PAF antagonistic benzofuran neolignans from Piper kadsura. Yaoxue Xuebao 28: 370-373, 1993; Chem. Abstr. 119: 151 841, 1993.
69. MacRae, W. D., Towers, G. H. N.: Biological activities of lignans. Phytochemistry 23: 1207-1220, 1984.
70. Massenet, G. M., Pando, E., Rodriguez-Luis, F., Zubia, E.: Lignans: a review. Fitoterapia 60: 3-35, 1989.
71. Matsumura, Y., Kita, S., Morimoto, S., Akimoto, K., Oka, N., Tanaka, T.: Antihypertensive effect of sesamin. I. Protection against deoxycortisone acetate-salt-induced hypertension and cardiovascular hypertrophy. Biol. Pharm. Bull. 18: 1016-1019, 1995.
72. Matsunaga, K., Shibuya, M., Ohimuzi, Y.: Graminone B, a novel lignan with vasodilative activity from Immperata cylindrica. J. Nat. Prod. 57: 1734-1736, 1994.
73. Matsunaga, K., Shibuya, M., Ohizumi, Y.: Imperanene, a novel phenolic compound with platelet aggregation inhibitory activity from Imperata cylindrica. J. Nat. Prod. 58: 138-139, 1995.
74. Metzger, H., Lindner, E.: The positive inotropic-acting forskolin, a potent adenylate cyclase activator. Arzneim.-Forsch. 31: 1248-1250, 1981.
75. Mimura, A., Takebayashi, K., Niwano, M., Takahara, Y., Osawa, T., Tokuda, H.: Antioxidative and anticancer components produced by cell culture of sesame. In: Ho, C.-T., Osawa, T., Huang, M.-T., Rosen, R. T. (Eds.): Food phytochemicals for cancer prevention II. American Chemical Society, Washington DC, pp. 281-294, 1994.
76. Moncada, S., Higgs, E. A., Vane, J. R.: Human arterial and venous tissues generate prostacyclin (prostaglandin X), a potent inhibitor of platelet aggregation. Lancet 1 (8001): 18-20, 1977.
77. Nikaido, T., Ohmoto, T., Noguchi, H., Kinoshita, T., Saitoh, H., Sankawa, U.: Inhibitors of cyclic AMP phosphodiesterase in medicinal plants. Planta Med. 43: 18-23, 1981 a.
78. Nikaido, T. Ohmoto, T., Kinoshita, T., Sankawa, U., Nishibe, S., Hisada, S.: Inhibitors of cyclic AMP phosphodiesterase in medicinal plants. II. Inhibition of cyclic AMP phosphodiesterase by lignans. Chem. Pharm. Bull. 29: 3586-3592, 1981 b.
79. Nishibe, S.: Bioactive phenolic compounds in traditional medicines. Pure Appl. Chem. 66: 2263-2266, 1994.
80. Nishibe, S., Tsukamoto, H., Hisada, S., Nikaido, T., Ohmoto, T., Sunkawa, U.: Inhibition of cyclic AMP phosphodiesterase by lignans and coumarins of Olea and Fraxintts bark. Shoyakngaku Zasshi 40: 86-94, 1986; Chem. Abstr. 105: 164 466, 1986.
81. Nishibe, S., Tsukamoto, H., Hisada, S., Nikaido, T., Ohmoto, T., Sunkawa, U.: Inhibition of cyclic AMP phosphodiesterase by lignans and coumarins of Olea and Fraxintts bark. Shoyakngaku Zasshi 40: 86-94, 1986; Chem. Abstr. 105: 164 466, 1986.
82. Nose, M., Fujimoto, T., Nishibe, S., Ogihara, Y.: Structural transformation of lignan compounds in rat gastrointestinal tract. II. Serum concentration of lignan and their metabolites. Planta Medica 59: 131-134, 1993.
83. Ogawa, H., Sagasawa, S., Murakami, T., Yoshizumi, H.: Sesame lignans modulate cholesterol metabolism in the stroke prone spontaneously hypertensive rat. Clin. Exp. Pharmacol. Physiol. 22: S 310-S 312, 1995.
84. Okuyama, E., Suzumura, K., Yamazaki, M.: Pharmacologically active components of Todopon Puok (Fagraea racemosa), a medicinal plant from Borneo. Chem. Pharm. Bull. 43: 2200-2204, 1995.
85. Pan, J.-X., Hensens, O. D., Zink, D. L., Chang, M. N., Hwang, S.-B.: Lignans with platelet activating factor antagonist activity from Magnolia biondi. Phytochemistry 26: 1377-1379, 1987.
86. Paré, P. W., Wang, H.-B., Davin, L. B., Lewis, N. G.: (+)-Pinoresinol synthase: A stereospecific oxidase catalysing 8, 8'-lignan formation in Forsythia intermedia. Tetrahedron Letters 35: 4731-4734, 1994.
87. Pelter, A.: Lignans: some properties and synthesis. Rec. Adv. Phytochem. 20: 201-241, 1986.
88. Plante, G. E., Prevost, C., Chainey, A., Braquet, P., Sirois, P.: Diuretic and natriuretic properties of prestegane B, a mammalian lignan. Am. J. Physiol. 253: R 375-R 378, 1987.
89. Rauwald, H. W., Brehm, O., Odenthal, K. P.: Screening of nine vasoactive medicinal plants for their possible calcium antagonistic activity. Strategy of selection and isolation for the active principles of Olea europaea and Peucedanum asthrutium. Phytother. Res. 8: 135-140, 1994.
90. Repke, K. R. H., Megges, R., Weiland, J., Schön, R.: Digitalis research in Berlin-Buch-retrospective and perspective views. Angew. Chemie Int. Ed. Engl. 34: 282-294, 1995.
91. Ross, R.: The pathogenesis of atherosclerosis: a perspective for the 1990's. Nature 362: 801-809, 1993.
92. Rüegg, U. T.: Ouabain - a link in the genesis of high blood pressure? Experientia 48: 1102-1105, 1992.
93. Sakurai, H., Nikaido, T., Ohmoto, T., Ikeya, Y., Mitsuhashi, H.: Inhibitors of adenosine 3', 5'-cyclic monophosphate phosphodiesterase from Schisandra chinensis and the structure activity relationship of lignans. Chem. Pharm. Bull. 40: 1191-1195, 1992.
94. Setchell, K. D., Lawson, A. M., Mitchell, F. L., Adlercreutz, H., Kirk, D. N., Axelson, M.: Lignans in man and animal species. Nature 287: 740-742, 1980.
95. Setchell, K. D., Lawson, A. M., Conway, E., Taylor, N. F., Kirk, D. N., Cooley, G., Farrant, R. D., Wynn, S., Axelson, M.: The definitive identification of the lignans trans-2, 3-bis(3-hydroxcylbenzyl)-gamma-butyrolactone and 2, 3-bis(3-hydroxybenzyl)butane-1, 4-diol in human and animal urine. Biochem. J. 197: 447-458, 1981.
96. Schiffrin, E. L.: Endothelin in hypertension. Curr. Opin. Cardiol. 10: 485-494, 1995.
97. Shen, T. Y.: Chemical and biochemical characterization of lignan analogs as novel PAF receptor antagonists. Lipids 26: 1154-1156, 1991.
98. Shen, T. Y., Hussaini, I. M.: Kadsurenone and other related lignans as antagonists of platelet-activating factor receptor. Meth. Enzym. 187: 446-454, 1990.
99. Sih, C. J., Ravikumar, P. R., Huang, F.-C., Buckner, C., Whitlock, H.: Isolation and synthesis of Pinoresinol diglucoside, a major antihypertensive principle of Tu-Chung (Eucommia ulmoides, Oliver.) J. Amer. Chem. Soc. 98: 5412-5413, 1976.
100. Suekawa, M., Shiga, T., Sone, H., Ikeya, Y., Taguchi, H., Aburada, M., Hosoya, E.: Effects of gomisin J and analogous lignan compounds in schisandra fruit on isolated smooth muscle. Yakugaku Zasshi 107: 720-726, 1987; Chem. Abstr. 108: 16 176, 1988.
101. Suekawa, M., Shiga, T., Sone, H., Ikeya, Y., Taguchi, H., Aburada, M., Hosoya, E.: Effects of gomisin J and analogous lignan compounds in schisandra fruit on isolated smooth muscle. Yakugaku Zasshi 107: 720-726, 1987; Chem. Abstr. 108: 16 176, 1988.
102. Sugano, M., Inoue, T., Koba, K., Yoshida, K., Hirose, N., Shinmen, Y., Akimoto, K., Amachi, T.: Influence of sesame lignans on various lipiod parameters in rats. Agr. Biol. Chem. 54: 2669-2674, 1990.
103. Tibirica, E. V., Mosquera, K., Abreu, M., Ribeiro, R., Carvalho, F. A. S., Barbosa, J. M., Cordeiro, R. S. B.: Antagonistic effect of yangambin on platelet-activating factor (PAF)-induced cardiovascular collapse. Phytomedicine 2: 235-242, 1996.
104. Vargaftig, B. B., Benveniste, J.: Platelet-activating factor today. Trends Pharmacol. Sci.: 341-343, 1983.
105. Wang, J., Shao, Y., Zhang, Y., Jiao, B., Dai, H., Yue, F.: Experimental studies of beta-phenyllactic acid on the coronary system. Acta. Academ. Med. Shanghai 18: 295-297, 1991.
106. Ward, R. S.: The synthesis of lignans and neolignans. Chem. Soc. Rev. 11: 75-125, 1982.
107. Ward, R. S.: Asymmetric synthesis of lignans. Tetrahedron 46: 5029-5041, 1990.
108. Ward, R. S.: Lignans, neolignans and related compounds. Nat. Prod. Rep. 10: 1-28, 1993.
109. Ward, R. S.: Lignans, neolignans and related compounds. Nat. Prod. Rep. 12: 183-205, 1995.
110. Warner, T. D., Elliott, J. D., Ohlstein, E. H.: California dreamin' 'bout endothelin: emerging new therapeutics. Trends Pharmacol. Sci. 17: 177-181, 1996.
111. Wu, T.-S., Leu, Y-L., Chan, Y.-Y., Yu, C-M., Su, J.-D.: Lignans and an aromatic acid from Cinnamomum philippinense. Phytochemistry 36: 785-788, 1994.
112. Xiao, P.-G., Fu, S.-L.: Pharmacologically active substances of chinese traditional and herbal medicines. In: Craker, L. E., Simon, L. E. (Eds.): Herb, Spices and Medicinal Plants, Food Products Press, New York, vol. 2, pp. 1-55, 1991.
113. Xu, J., Li, Y., Liang, Z.: Effects of tetramethylpyrazine and ferulic acid alone or combined on vascular smooth muscle, blood viscosity, and toxicity. Zhongyao Zazhi 17: 680-682, 1992; Chem. Abstr. 115: 73 396, 1993.
114. Xu, J., Li, Y., Liang, Z.: Effects of tetramethylpyrazine and ferulic acid alone or combined on vascular smooth muscle, blood viscosity, and toxicity. Zhongyao Zazhi 17: 680-682, 1992; Chem. Abstr. 115: 73 396, 1993.
115. Yamadaki, M., Shimoyama, A.: Glucosides from Eucommia ulmoides Jpn Kokai Tokkyo JP 04,244,030, 1992. Chem. Abstr. 118: 66 841, 1993.
116. Yamazaki, R., Sugatani, J., Fujii, I., Kuroyanagi, M., Umehara, K., Ueno, A., Suzukj, Y., Miwa, M.: Development of a novel method for determination of acetyl-CoA:1-alkyl-sn-glycero-3-phosphocholine acetyl transferase activity and its application to screening for acetyl transferase inhibitors. Inhibition by magnolol and honokiol from Magnoliae cortex. Biochem. Pharmacol. 47: 995-1006, 1994.
117. Yeh, L.-A., Chen, J., Baculi, F., Gingrich, D. E., Shen, T. Y.: Inhibition of metalloproteinase by futoenone derivatives. Bioorg. Med. Chem. Lett. 5: 1637-1642, 1995.
118. Yokozawa, T., Zhou, J. J., Oura, H., Tanaka, T., Nonaka, G., Nishioka, I.: Effects on blood pressure of caffeic acid analogues isolated from salviae miltorrhiza radix in rats with adenine induced renal hypertension. Phytother. Res. 9: 105-109, 1995.
119. Zhang, S.-X., Chen, K., Liu, X.-J., Zhang, D.-C., Tao-Wiedmann, T.-W., Leu, S.-L., McPhail, A. T., Lee, K.-H.: The isolation and structural elucidation of three new neolignans, puberulins A, B, and C, as platelet activating factor receptor antagonists from Piper puberulum. J. Nat. Prod. 58: 540-547, 1995.
120. 2 contents in the plasma of rabbits after coronary artery occlusion. Zongguo Yaoli Yuebao 7: 533-536, 1986; Chem. Abstr. 106: 27 586, 1987.
121. 2 contents in the plasma of rabbits after coronary artery occlusion. Zongguo Yaoli Yuebao 7: 533-536, 1986; Chem. Abstr. 106: 27 586, 1987.